Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Wall Street Journal: China's Drug Development Goes Global

publication date: Apr 10, 2017
For years, China has been promoting itself as a source of innovative drug development. And there's a lot going on. But China still has to prove itself: it needs to develop a novel drug that is accepted in the west. As the Wall Street Journal pointed out in an article using data from ChinaBio®, China is closing in on that milestone. Several western companies plan to start trials of China-discovered novel drugs, and China has become a powerhouse in the field of biologic drugs, the most advanced, most lucrative sector of drug development. Over the past ten years, China has progressed from a promising source of novel drugs to an essential one. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital